Abstract
Both denuding and nondenuding endothelial injury have been proposed as pathogenetic mechanisms in atherogenesis. Conversion of a nondenuding injury to a denuding one, however, is not considered to be a rare event. Although both mechanisms initiate different molecular pathways, they ultimately lead to 1) proliferation of smooth muscle cells; 2) synthesis of connective tissue matrix; 3) focal accumulation of monocytes/macrophages; 4) lymphocytic infiltration; and 5) variable intracellular and extra-cellular lipid accumulation and eventually stenotic lesions [1].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Wilcox JN, Harker LA: Molecular and cellular mechanisms of atherogenesis: studies of human lesions linked with animal modeling. In Haemostasis and Thrombosis, edn 3, vol 2. Edited by Bloom AL, Forbes CD, Thomas DP, et al. Edinburgh: Churchill Livingstone; 1993, 1139–1152.
Cybulsky MI, Gimbrone MA: Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 1991, 251: 788–791.
Celermajer DS: Endothelial dysfunction: does it matter? is it reversible? J AmColl Cardiol 1997, 30: 325–333.
Bar Shavit R, Benezra M, Sabbah V, et al.: Thrombin as a multifunctional protein: induction of cell adhesion and proliferation. Am J Respir Cell Mol Bio1 1992; 6:123–130.
Shultz PJ, Knauss TC, Mene P, et al.: Mitogenic signals for thrombin in mesangial cells: regulation of phospholipase C and PDGF genes. Am J Physiol 1989, 257(suppl F):366–374.
Zhang Y, Cliff WJ, Schoefl GI, et al.: Plasma protein insudation as an index of early coronary atherogenesis. Am J Pathol 1993, 143:496–505.
Evanko SP, Raines EW, Ross R, et al.: Proteoglycan distribution in lesions of atherosclerosis depends on lesion severity, structural characteristics, and the proximity of platelet-derived growth factor and transforming growth factor-ß. Am J Pathol 1998, 152:533–546.
McEvoy LM, Sun H, Tsao PS, et al.: Novel vascular molecule involved in monocyte adhesion to aortic endothelium in models of atherogenesis. J Exp Med 1997, 185:2069–2077.
McGill HC Jr: Persistent problems in the pathogenesis of atherosclerosis. Arteriosclerosis 1984, 4: 443–451.
Tracy RE, Kissling GE: Age and fibroplasia as preconditions for atheronecrosis in human coronary arteries. Arch Pathol Lab Med 1987, 111: 957–963.
Van Der Wal AC, Das PK, Van Der Berg DB, et al.: Atherosclerotic lesions in humans: in situ immunophenotypic analysis suggesting an immune-mediated response. Lab Invest 1989, 61:166–170.
Wilcox JN: Analysis of local gene expression in human atherosclerotic plaques by in situ hybridization. Trends Cardiovasc Med 1991, 1: 17–24.
Wilcox JN, Smith KM, Williams LT, et al.: Platelet derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization. J Clin Invest 1988, 82:1134–1143.
Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990’s. Nature 1993, 362: 801–809.
Gerrity RG, Goss JA, Soby L: Control of monocyte recruitment by chemotactic factor(s) in lesion-prone areas of swine aorta. Atherosclerosis 1985, 5: 55–66.
Rose R: Atherosclerosis: a defence mechanism gone awry. Am J Pathol 1993, 143: 987–1002.
Fuster V, Badimon JJ, Badimon L: Clinical-pathological correlations of coronary disease progression and regression. Circulation 1992, 86 (suppl 6): 1–11.
Richardson PD, Davies MS, Born GVR: Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques. Lancet 1989, 2: 941–944.
Bini A, Fenoglio JJ Jr, Mesa-Tejada R, et al.: Identification and distribution of fibrinogen, fibrin and fibrin(ogen) degradation products in atherosclerosis: use of monoclonal antibodies. Arteriosclerosis 1989, 9:109–121.
Lendon C, Davies M, Born G, et al.: Atherosclerotic plaque caps are locally weakened when macrophage density is increased. Atherosclerosis 1991, 65:302–310.
Amento EP, Ehsani N, Palmer H, et al.: Cytokines positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arterioscler Thromb 1991, 11:1223–1230.
Libby P: Molecular bases of the acute coronary syndromes. Circulation 1995, 91: 2844–2850.
Kovanen PT, Koaartinen M, Paavonen T: Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation 1995, 92: 1084–1088.
Nissen S, Gurley J, Booth D, et al.: Differences in ultrasound plaque morphology in stable and unstable patients [abstract]. Circulation 1991, 84:436.
Davies MJ, Richardson PD, Woolf N, et al.: Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophages and smooth muscle cell content. Br Heart J 1993, 69:377–381.
Zhang Y, Cliff WJ, Shoefl GI, et al.: Immunohistochemical study of intimal microvessels in coronary atherosclerosis. Am J Pathol 1993, 43:164–172.
Nicosia RF, Lin YJ, Hazelton D, et al.: Endogenous regulation of angiogenesis in the rat aorta model: role of vascular endothelial growth factor. Am J Pathol 1997, 151:1379–1386.
Demer LL: A skeleton in the atherosclerosis closet. Circulation 1995, 92: 2029–2032.
Hirota S, Imakita M, Kohri K, et al.: Expression of osteopontin messenger RNA by macrophages in atherosclerotic plaques. Am J Pathol 1993,143:1003–1008.
Demer LL: Lipid hypothesis of cardiovascular calcification. Circulation 1997, 95: 297–298.
Guyton JR, Klemp KF: The lipid-rich core region of human athero- sclerotic fibrous plaques: prevalence of small lipid droplets and vesicles by electron microscopy. Am J Pathol 1989, 134: 705–717.
Podet EJ, Shaffer DR, Gianturco SH, et al.: Interaction of low density lipoproteins with human aortic elastin. Arterioscler Thromb 1991, 1:11:116.
Falk E: Why do plaques rupture? Circulation 1992, 86 (suppl III): 30–42.
Theroux P, Foster V: Acute coronary syndromes: unstable angina and non-Q-wave myocardial infarction. Circulation 1998, 97: 1195–1206.
Stary HC: The sequence of cell and matrix changes in atherosclerotic lesions of coronary arteries in the first forty years of life. Eur Heart J 1990, 11 (suppl E): 3–19.
Davies MJ: Stability and instability: two faces of coronary atherosclerosis. Circulation 1996, 94: 2013–2020.
Lewis LC, Bennet-Cain AL, DeMars CS, et al.: Procoagulant activity after exposure of monocyte-derived macrophages to minimally oxidized low density lipoprotein. Am J Pathol 1995, 147:1029–1040.
Shah PK, Falk E, Badimon JJ, et al.: Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques: potential role of matrix-degrading metalloproteinases and implication for plaque rupture. Circulation 1995, 92:1565–1569.
Badimon L, Chesebro JH, Badimon JJ: Thrombus formation on ruptured atherosclerotic plaques and rethrombosis on evolving thrombi. Circulation 1992, 86 (suppl 6): 74–85.
Nachman RL: Lipoprotein (alpha): molecular mischief in the microvasculature. Circulation 1997, 96: 2485–2487.
Schachinger V, Halle M, Minners J, et al.: Lipoprotein (alpha) selectively impairs receptor-mediated endothelial vasodilator function of the human coronary circulation. J Am Cell Cardiol 1997, 30:927–934.
Lopez-Candales A, Holmes, DR, Liao S, et al.: Decreased vascular smooth muscle cell density in medial degeneration of human abdominal aortic aneurysms. Am J Pathol 1997, 150:993–1007.
Loscalzo J, Weinfeld M, Fless GM, et al.: Lipoprotein (alpha), fibrin binding, and plasminogen activation. Arteriosclerosis 1990, 10:240–245.
Koch AE, Kunkel SL, Pearce WH, et al.: Enhanced production of the chemotactic cytokines interleukin-8, and monocyte chemoattractant protein-1 in human abdominal aortic aneurysms. Am J Pathol 1993, 142:1423–1431.
Hanson GK, Jonasson S, Seifert PS, et al.: Immune mechanisms in atherosclerosis. Arteriosclerosis 1989, 9:567–578.
Koch AE, Haines K, Rizzo RJ, et al.: Human abdominal aortic aneurysms: immunophenotypic analysis suggesting an immune-mediated response. Am J Pathol 1990, 137: 1199–1213.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Science+Business Media New York
About this chapter
Cite this chapter
Gravanis, M.B. (2000). Histopathology of Arteriosclerosis. In: Wilson, P.W.F. (eds) Atlas of Atherosclerosis. Current Medicine Group, London. https://doi.org/10.1007/978-1-4757-9310-9_1
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9310-9_1
Publisher Name: Current Medicine Group, London
Print ISBN: 978-1-4757-9312-3
Online ISBN: 978-1-4757-9310-9
eBook Packages: Springer Book Archive